Business
Easton Pharmaceuticals and BMV Medica Sign MOU Towards Exclusive Distribution for Woman's Patented Diagnostic Test for Amniotic Fluid Detection for Women in Late Pregnancy for the Majority of Latin American Countries
Easton Pharmaceuticals and BMV Medica Sign MOU Towards Exclusive Distribution for Woman's Patented Diagnostic Test for Amniotic Fluid Detection for Women in Late Pregnancy for the Majority of Latin American Countries.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals and BMV Medica Sign MOU Towards Exclusive Distribution for Woman's Patented Diagnostic Test for Amniotic Fluid Detection for Women in Late Pregnancy for the Majority of Latin American Countries\n \n \nEaston Pharmaceuticals and BMV Medica Sign MOU Towards Exclusive Distribution for Woman's Patented Diagnostic Test for Amniotic Fluid Detection for Women in Late Pregnancy for the Majority of Latin American Countries\n\nMany Countries in the Region Accept US-FDA Approvals With a Minimum Amount of Extra Documentation, Easton / BMV Could Effectively Begin Selling This New Test in These Countries Pending Agreements With Local Distributors\n\n \n TORONTO, ON--(Marketwired - Jun 18, 2015) - Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has signed an MOU with BMV Medica SA de CV towards the exclusive distribution for most Latin American countries including Argentina, Chile, Colombia, Peru and Ecuador and all of Central America for a patented Diagnostic Test for the only non-invasive monitoring test for amniotic fluid leaks for women in late-stage pregnancies.\n The Amniotic Fluid Leak Detection Test -- a valuable new diagnostic test for which Easton / BMV now have the exclusive rights to Latin America, which will enhance Easton / BMV 's franchise and commitment in women's health products. Since many countries in the region accept US-FDA approvals with a minimum amount of extra documentation, Easton / BMV could begin selling this new test in these countries pending agreements with local distributors.\n With the pregnancy and birth rates much higher in Latin America than in Western countries like the European Community, the US and Canada, Easton / BMV believe this amniotic fluid leak test will be a success upon launch. This test competes with much more cumbersome, expensive and hard-to-use products, and can be worn as a panty-liner by women during the latter stage of their pregnancy for both detection and prophylaxis.\n From a sales & marketing perspective, the same Obstetrician / Gynecologist who would recommend the use of the vaginal detection test would also have at their disposal the ability to recommend use of this amniotic fluid detection test for their late-stage pregnant patients. BMV / Easton believe this new rapid test will quickly gain broad acceptance by many Doctors and women who...